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Abstract
Objectives—The purpose of this study was to estimate the prevalence of major and minor 
congenital heart defects among fetuses and neonates using sonography in a general population of 4 
areas surrounding Shanghai, China.
Methods—Pregnant women were recruited between April 2004 and December 2005 in Jiaxing 
City, Suzhou City, Changshu County, and Haining County. All participants could have 3 
sonographic examinations performed by specially trained physicians regardless of medical 
indication: a fetal sonographic screen and fetal echocardiography between 20 and 28 weeks’ 
gestation and neonatal echocardiography. Diagnoses of congenital heart defects were made on the 
basis of review of all available scans by an international group of experts in pediatric cardiology. 
Prevalence rates were calculated per 1000 births.
Results—Among 4006 scanned fetuses and neonates, there were 75 congenital heart defects, 
including 12 major defects. The observed prevalence for all congenital heart defects was 18.7 
(95% confidence interval, 14.8–23.5) per 1000 births, and the prevalence for major defects was 
3.0 (95% confidence interval, 1.6–5.2) per 1000 births. The most common defects were 
ventricular septal defects (n = 47 [62.7%]), atrial septal defects (n = 14 [18.7%]), tetralogy of 
Fallot (n = 4 [5.3%]), and hypoplastic left heart syndrome (n = 3 [4.0%]).
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Conclusions—The prevalence of all congenital heart defects in the 4 areas of China studied was 
higher than that reported in other countries, with ventricular septal defects being the most frequent 
defects. Our data likely reflect a better estimate of the total prevalence of congenital heart defects 
in China than reported previously.
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Congenital heart defects are the leading cause of infant mortality due to birth defects. In 
countries with low infant mortality rates, almost half of infant deaths are attributable to 
congenital heart defects directly or indirectly.1,2 Early studies in developed western 
countries have reported overall congenital heart defect prevalence estimates of 4 to 10 per 
1000 live births3–5 and 2.6 to 4.4 per 1000 births for major defects,6–8 defined as defects 
requiring catheter or surgical intervention during the first year of life. The prevalence of 
congenital heart defects among fetuses is estimated to be even higher, at 14.6 per 1000 
fetuses.9 Because complex congenital heart defects are common among fetuses10 and may 
result in spontaneous abortion or stillbirth, the total prevalence of congenital heart defects 
among stillbirths and live births may be higher than that reported among live births alone. 
The prevalence of congenital heart defects may also be underestimated because minor 
defects may be asymptomatic and undetected among neonates. More comprehensive 
surveillance among fetuses and neonates would improve prevalence estimates for congenital 
heart defects and help assess prevention efforts.
With the wider use of prenatal and postnatal sonography to diagnose congenital heart 
defects, observed prevalence estimates have risen. Although sonographic investigations to 
detect congenital malformations are routinely performed between 13 and 22 weeks’ 
gestation in most European counties,11–13 routine sonography may still miss some defects, 
especially outflow tract defects and small septal defects.14 Specialized fetal or neonatal 
echocardiography is usually performed only when there is a risk of a congenital heart defect 
or it is suspected. Thus, the total prevalence of congenital heart defects in a general 
population is unclear regardless of medical indication.
In most parts of China, sonographic screening for malformations was seldom used during 
routine prenatal health care until the 1990s. Thus, early congenital heart defect prevalence 
estimates of 2.7 to 6.6 per 1000 live births in China based on postnatal case ascertainment 
alone might be lower than those reported in some developed countries.15,16 Recently, 
hospital-based studies of prenatal congenital heart defect detection have been conducted in 
China,17–19 and 1 large population-based study, which performed echocardiography on 
fetuses and neonates suspected of having congenital heart defects, reported a prevalence rate 
of 8.2 per 1000 births.20
Given the recent increased use of fetal sonography in China, a surveillance program was 
initiated in 4 areas surrounding Shanghai to investigate the prevalence of congenital heart 
defects among all fetuses and neonates in a Chinese general population regardless of 
medical indication.
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Materials and Methods
Study Initiation
This prospective cohort study was conducted through a cooperative agreement between the 
US Centers for Disease Control and Prevention and the Peking University Health Science 
Center to develop a surveillance program for congenital heart defects from April 2004 to 
December 2005 at 18 hospitals in 4 areas surrounding Shanghai: Jiaxing City and Haining 
County in Zhejiang Province and Suzhou City and Changshu County in Jiangsu Province. 
An already-established centralized perinatal health care surveillance system monitors all 
pregnancies, recording outcomes, prenatal and postnatal visits, demographics, and medical 
histories. All women receive prenatal care at local township hospitals, which are part of the 
city or county health care systems.
Before the study began, a team of pediatric cardiology experts from several cities in the 
United States and Canada developed a 1-week training program in cardiac imaging for local 
Chinese sonographers. One course trained township sonographers to include the 4 chambers, 
outflow tracts, and views of the great arteries in their routine fetal sonographic screens. 
Another course trained county sonographers to obtain satisfactory fetal echocardiographic 
images. Ultrasound equipment used in township hospitals included Hi Vision (Hitachi 
Medical Systems, Tokyo, Japan), LOGIQ 3 (GE Healthcare, Milwaukee, WI), and 
SSA-320A (Toshiba Medical Systems, Tokyo, Japan). Echocardiographic equipment 
included Sonos 5500 (Philips Healthcare, Eindhoven, the Netherlands), LOGIQ 7 and 
Voluson 730 (GE Healthcare), and Sequoia 512 (Siemens Medical Solutions, Mountain 
View, CA).
Study Methods
All pregnant women presenting to a township hospital for the first prenatal visit at less than 
25 weeks’ gestation were eligible for the study. Assuming a baseline congenital heart defect 
prevalence of 15 per 1000 at P < .05 (2-sided test) and a total width of the estimate precision 
of 4 per 1000, we calculated that 3548 patients needed to be screened. We used systematic 
convenience sampling to invite the first 4 eligible women who visited any of the study 
hospitals each day to participate.
Ideally, 3 sonographic examinations were to be performed on each participant: (1) a fetal 
sonographic screen at a township hospital, (2) fetal echocardiography at a city or county 
hospital between 20 and 28 weeks’ gestation, and (3) neonatal echocardiography within 7 
days of birth. All images were video recorded on compact disks for subsequent review and 
diagnosis by pediatric cardiologists. In the event of a stillbirth or perinatal death, a 
pathologist was to examine the fetus or neonate for congenital malformations. If the fetus or 
neonate had normal findings from only a single fetal examination (fetal sonographic screen 
or fetal echocardiography) and no neonatal echocardiography, the fetus’s or neonate’s health 
records were checked for evidence of a previously undiagnosed congenital heart defect (ie, 
false-negative prenatal examination findings).
A multistage process determined the presence of a congenital heart defect. First, all 
examinations were reviewed by a city cardiologist, who made the primary diagnosis. Then, 
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Peking University Health Science Center cardiologists and the international team of experts 
reviewed the abnormal findings and a 10% sample of all normal findings to corroborate the 
findings. The final diagnosis was based on the neonatal echocardiographic findings; if there 
were none, the findings from fetal echocardiography or autopsy were used. The experts 
reached consensus on cases with discrepant findings during a workshop at the study’s 
conclusion. An isolated patent foramen ovale and patent ductus arteriosus among neonates 
(ie, <28 days of life) were excluded because they are normal neonatal findings.
The study was approved by the Institutional Review Boards at the Centers for Disease 
Control and Prevention and the Peking University Health Science Center. All invited 
participants provided informed consent before any study activities.
Statistical Analysis
Prevalence estimates were reported per 1000 births (defined as pregnancies ≥20 weeks’ 
gestation). Binomial 95% confidence intervals were computed for the observed prevalence 
rates. All P values were 2 sided at a level of P < .05. The significance of categorical 
variables was assessed by a χ2 test or Fisher exact test. The data were analyzed with SPSS 
version 11.5 statistical software 11.5 (SPSS Inc, Beijing, China).
Results
Sociodemographic Characteristics
Among the 4477 pregnant women invited to participate in the study, 495 declined and 3982 
enrolled. Sociodemographic characteristics of participants and nonparticipants (women who 
were pregnant during the same interval and from the same geographic locations) are 
presented in Table 1. Although study participants and nonparticipants were statistically 
different in all sociodemographic characteristics, the distributions of the two groups by these 
characteristics were generally similar.
Examination Completeness
A total of 4006 fetuses were examined (3958 singletons and 48 twins). As shown in Table 2, 
3965 (99.0%) had a fetal sonographic screen; 3737 (93.3%) had fetal echocardiography; 
3404 (85.0%) had neonatal echocardiography; and 3331 (83.2%) completed all 3 
sonographic examinations. More than 60% of the neonatal echocardiographic studies were 
completed within 7 days after birth, and 90% were completed within 28 days. Among 216 
fetuses (5%) who had only a fetal sonographic screen (no fetal echocardiography or neonatal 
echocardiography), 208 were live born without signs or symptoms of a congenital heart 
defect in infancy or childhood and thus were presumed not to have a defect. For the 
remaining 8 fetuses (0.2%), the congenital heart defect status could not be confirmed. These 
fetuses included 4 singleton pregnancies that were terminated after having diagnoses of 
other major birth defects during the fetal sonographic screen and 2 stillbirths (all without 
autopsy). Two additional pregnancies were lost to follow-up.
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Diagnosis of Congenital Heart Defects
Among the 4006 fetuses and neonates who were scanned prenatally or neonatally, we 
identified 75 congenital heart defects, for an overall observed prevalence of 18.7 (95% 
confidence interval, 14.8–23.5) per 1000 births. The most common congenital heart defects 
were ventricular septal defects (VSDs; n = 47 [62.7%]) and atrial septal defects (ASDs; n = 
14 [18.7%]; Table 3).
Of the 75 congenital heart defects, 16.0% (n = 12) were major, for an observed prevalence 
of 3.0 (95% confidence interval, 1.6–5.2) per 1000 births. There were 10 cases of major 
defects (83.3%), which were detected in utero; 8 of the associated pregnancies were 
terminated. For cultural reasons, autopsies are seldom conducted in China; therefore, 
autopsies to confirm the diagnoses were performed for only 3 of the terminations. Four of 
the 12 neonates with major defects were live born. One neonate died before neonatal 
echocardiography could confirm a diagnosis of transposition of the great arteries made in 
utero. Two neonates had normal fetal examination findings, but on neonatal 
echocardiography, 1 was found to have mild (pink) tetralogy of Fallot, and the other was 
found to have total anomalous pulmonary venous return. The fourth live-born neonate had a 
diagnosis of only a VSD (a minor defect) on fetal echocardiography but postnatally was 
discovered to have mild (pink) tetralogy of Fallot on neonatal echocardiography (a major 
defect; Table 4).
Only 2 minor defects (VSDs) were diagnosed in utero; the remaining 61 minor defects were 
identified by neonatal echocardiography in the face of previous normal prenatal examination 
findings. Thus, the prenatal detection rate for all congenital heart defects based on fetal 
echocardiography was 16% (12 of 75). The prenatal detection rate of 3% (2 of 63) for minor 
defects was significantly lower than the rate of 83% (10 of 12) for major defects (P < .0001).
Discussion
This population-based study in China used sonography to determine the observed prevalence 
of congenital heart defects among fetuses and neonates in 4 areas around Shanghai. We 
found a relatively high overall prevalence of congenital heart defects (18.7 per 1000), most 
of which were minor (84%), diagnosed or confirmed postnatally. Conversely, the prevalence 
of major defects was 3.0 per 1000, 75% of which were diagnosed prenatally by fetal 
echocardiography. The prenatal detection rate for minor defects was significantly lower than 
the rate for major defects.
The total observed prevalence of congenital heart defects was higher than that found in other 
studies,15,20–24 primarily because of the large number of minor defects that were diagnosed 
postnatally on neonatal echocardiography. Ventricular septal defects were the most common 
defects, accounting for 62.7% of all cases. In recent years, as the use of echocardiography 
has increased, the detection rate of small VSDs has also increased considerably. Many 
surveillance studies found that 30% to 40% of congenital heart defects were VSDs,25–27 and 
some suggested that the overall prevalence of congenital heart defects depends mainly on 
the prevalence of VSDs.28 The findings from this study support the previously reported 
findings that VSDs are the most frequent defects and suggest that the percentage of VSDs in 
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a systematically screened population may be even higher than previously reported. Our 
prevalence estimates for other congenital heart defect types were similar to those noted 
previously.29–31 In most clinical settings, neonates have neonatal echocardiography only if 
medically indicated. However, in this screening study, all neonates were to undergo neonatal 
echocardiography; thus, more minor congenital heart defects (eg, small VSDs) were 
diagnosed than might have otherwise been detected in a medically indicated population.
Our observed prevalence rate for major congenital heart defects was similar to those in 
recent reports.6–8 Similar to another Chinese study, most prenatally diagnosed defects were 
major, whereas minor defects were predominantly diagnosed postnatally.20 In our study 
population, as in that of the previous Chinese study, most pregnancies with major defects 
were terminated and did not receive a confirmatory diagnosis (ie, neonatal echocardiography 
or autopsy). Although 1 neonate did have a diagnostic change from VSD to tetralogy of 
Fallot after neonatal echocardiography, it is unlikely that misdiagnosis would have 
substantially altered the prevalence of major defects because studies have shown good 
concordance between prenatal and postnatal studies for many of the congenital heart defect 
types we studied.32
Prevalence estimates for congenital heart defects are highly dependent on surveillance 
methods. Some studies based on results of fetal echocardiography done only on neonates 
with suspected defects11,33 might have missed some cases of small VSDs, ASDs, and 
coarctation of the aorta, which are not reliably diagnosed prenatally. A recent study in 
fetuses and neonates in Beijing reported a prevalence rate of 8.2 per 1000 births, which was 
lower than our estimates, perhaps because only those at risk for congenital heart defects 
were examined. In contrast, higher prevalence rates were reported by some studies that 
examined all or almost all neonates in a region and detected large numbers of small VSDs 
and other minor defects.9,30
One strength of this study was that it was a population-based surveillance study in which 
most fetuses had 2 fetal examinations after 20 weeks’ gestation, and neonates had neonatal 
echocardiography to detect congenital heart defects. Sonographic examinations were 
performed regardless of risk factors or clinical symptoms. Furthermore, multiple 
examination reviews by experts minimized the potential for misdiagnosis. Thus, our data 
likely reflect an improved estimation of the prevalence of congenital heart defects in 
southeastern China.
Another study strength was that systematic sampling avoided a selection bias. Although 
there were statistical differences in sociodemographic characteristics between participants 
and nonparticipants, these differences were of a small magnitude and likely not meaningful, 
reflecting a comparison of two groups with a greater than 3-fold difference in sample size. 
Because the nonparticipant sample was relatively small, the participants’ sociodemographic 
characteristics likely represented all local pregnant women.
One limitation of this study was the difficulty in distinguishing between an ASD and a 
patent foramen ovale in the neonatal period. The exclusion of a patent ductus arteriosus and 
patent foramen ovale in neonates (<28 days of life) eliminated neonatal conditions (ie, false-
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positive findings) from consideration, thereby improving the prevalence estimates of 
congenital heart defects. However, among our 14 cases of ASDs (18.7%), several were 
difficult to distinguish from a patent foramen ovale. Thus, our prevalence data might 
represent an overestimation of ASDs among this population.
Our study had other limitations. There was no long-term follow-up to determine whether 
cases of small VSDs and ASDs spontaneously closed. Furthermore, because some 
pregnancies with prenatally diagnosed congenital heart defects were terminated before 
having confirmatory neonatal echocardiography, the accuracy of the fetal echocardiographic 
diagnoses in this population was uncertain. There might also have been unknown early 
miscarriages before the examinations were done. Furthermore, our project was 
geographically limited and might not represent the prevalence of congenital heart defects 
throughout China. Finally, the performance and interpretation of prenatal cardiac 
sonographic examinations are highly dependent on operator and interpreter expertise. Our 
study sonographers and Chinese reviewers had little experience in fetal cardiac sonography 
before the training program in this study, which might have affected the quality of the 
results. Despite these limitations, this study, using prenatal and neonatal diagnoses, found a 
higher prevalence rate for congenital heart defects than other reports. Thus, these results 
potentially represent minimal estimates of congenital heart defect prevalence in southeastern 
China.
In conclusion, in 4 areas surrounding Shanghai, the observed population-based prevalence of 
all congenital heart defects was 18.7 per 1000 births, and the prevalence of major defects 
was 3.0 per 1000 births. This overall prevalence was higher than rates reported in other 
countries, partially reflecting the inclusion of a large proportion of minor defects detected by 
echocardiographic examination of all neonates. Nevertheless, our data probably reflect an 
improved minimal estimate of the total prevalence of congenital heart defects in China.
Acknowledgments
We thank Shixin Hong, MD (Peking University Health Science Center), Ann Chao, PhD (Centers for Disease 
Control and Prevention), Taimei Wang, MD, Xiujing Kou, MD, Zhaoping Li, MD, and Weihong Li, MD (Peking 
University Third Hospital), Chunyan Shi, MD (Peking University First Hospital), Yongqing Li, MD (Chinese 
Academy of Medical Science Fuwai Hospital), Guizhen Zhang, MD, and Bin Geng, MD (Beijing Anzhen Hospital, 
Capital University of Medical Science), and government, public health, and maternal and child health workers from 
the Zhejiang and Jiangsu provincial, city, county, and township levels in China. This work was supported in part by 
cooperative agreement U11/CCU015586 from the Centers for Disease Control and Prevention.
Abbreviations
ASD atrial septal defect
VSD ventricular septal defect
References
1. Anderson RN, Smith BL. Deaths: leading causes for 2001. Natl Vital Stat Rep. 2003; 52:1–85.
2. Boyd PA, Armstrong B, Dolk H, et al. Congenital anomaly surveillance in England: ascertainment 
deficiencies in the national system. BMJ. 2005; 330:27. [PubMed: 15561730] 
Zhang et al. Page 7
J Ultrasound Med. Author manuscript; available in PMC 2015 June 17.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
3. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002; 
39:1890–1900. [PubMed: 12084585] 
4. Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The 
Baltimore-Washington Infant Study. Am J Epidemiol. 1985; 121:31–36. [PubMed: 3964990] 
5. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital 
heart defects in metropolitan Atlanta, 1998–2005. J Pediatr. 2008; 153:807–813. [PubMed: 
18657826] 
6. Acharya G, Sitras V, Maltau JM, et al. Major congenital heart disease in Northern Norway: 
shortcomings of pre- and postnatal diagnosis. Acta Obstet Gynecol Scand. 2004; 83:1124–1129. 
[PubMed: 15548143] 
7. Schultz AH, Localio AR, Clark BJ, Ravishankar C, Videon N, Kimmel SE. Epidemiologic features 
of the presentation of critical congenital heart disease: implications for screening. Pediatrics. 2008; 
121:751–757. [PubMed: 18381540] 
8. Hunter S, Heads A, Wyllie J, Robson S. Prenatal diagnosis of congenital heart disease in the 
northern region of England: benefits of a training programme for obstetric ultrasonographers. Heart. 
2000; 84:294–298. [PubMed: 10956294] 
9. Tegnander E, Williams W, Johansen OJ, Blaas HG, Eik-Nes SH. Prenatal detection of heart defects 
in a non-selected population of 30,149 fetuses: detection rates and outcome. Ultrasound Obstet 
Gynecol. 2006; 27:252–265. [PubMed: 16456842] 
10. Tennstedt C, Chaoui R, Korner H, Dietel M. Spectrum of congenital heart defects and extracardiac 
malformations associated with chromosomal abnormalities: results of a seven year necropsy study. 
Heart. 1999; 82:34–39. [PubMed: 10377306] 
11. Garne E, Stoll C, Clementi M. Evaluation of prenatal diagnosis of congenital heart diseases by 
ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol. 2001; 17:386–
391. [PubMed: 11380961] 
12. International Society of Ultrasound in Obstetrics and Gynecology. Cardiac screening examination 
of the fetus: guidelines for performing the “basic” and “extended basic” cardiac scan. Ultrasound 
Obstet Gynecol. 2006; 27:107–113. [PubMed: 16374757] 
13. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the 
effectiveness of routine prenatal screening for major congenital heart defects. Heart. 2002; 
88:387–391. [PubMed: 12231598] 
14. Khoo NS, Van Essen P, Richardson M, Robertson T. Effectiveness of prenatal diagnosis of 
congenital heart defects in South Australia: a population analysis, 1999–2003. Aust NZ J Obstet 
Gynaecol. 2008; 48:559–563.
15. Yan HQ, Chen YH, Ying CN. Survey on the prevalence of congenital heart disease of 17,933 
children aged 0–2 y. Chin Women Child Health Care. 2006; 21:82–83.
16. Zhang Z, Li Z, Ji C. Prevalence study of congenital heart disease in children aged 0–2 in Zhejiang 
Province [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi. 1999; 20:155–157. [PubMed: 
10682526] 
17. Wei DH, He HQ, Liang X, et al. Value of screening for fetal congenital heart diseases with two-
dimensional echocardiography extensively. Chin Women Child Health Care. 2007; 22:2122–2124.
18. Liu J, Liu Y, Zhang M, et al. Clinical significance of color Doppler echocardiography in diagnosis 
of fetal congenital heart disease in prenatal. J Chin Mod Imaging. 2005; 2:139–140.
19. Shi C, Song L, Li Y, Dai S. Value of four-chamber view of the fetal echocardiography for the 
prenatal diagnosis of congenital heart disease. Chin J Obstet Gyneco1. 2002; 37:385–387.
20. Yang XY, Li XF, Lu XD, Liu YL. Incidence of congenital heart disease in Beijing, China. Chin 
Med J (Engl). 2009; 122:1128–1132. [PubMed: 19493457] 
21. Amorim LF, Pires CA, Lana AM, et al. Presentation of congenital heart disease diagnosed at birth: 
analysis of 29,770 newborn infants. J Pediatr (Rio J). 2008; 84:83–90. [PubMed: 18204741] 
22. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general 
population: changing prevalence and age distribution. Circulation. 2007; 115:163–172. [PubMed: 
17210844] 
Zhang et al. Page 8
J Ultrasound Med. Author manuscript; available in PMC 2015 June 17.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
23. Chen QH, Wang XQ, Qi SG. Cross-sectional study of congenital heart disease among Tibetan 
children aged from 4 to 18 years at different altitudes in Qinghai Province. Chin Med J (Engl). 
2008; 121:2469–2472. [PubMed: 19187580] 
24. Uner A, Doğan M, Bay A, Cakin C, Kaya A, Sal E. The ratio of congenital heart disease and 
innocent murmur in children in Van city, the Eastern Turkey. Anadolu Kardiyol Derg. 2009; 9:29–
34. [PubMed: 19196570] 
25. Cymbron T, Anjos R, Cabral R, Macedo C, Pereira Duarte C, Mota-Vieira L. Epidemiological 
characterization of congenital heart disease in São Miguel Island, Azores, Portugal. Community 
Genet. 2006; 9:107–112. [PubMed: 16612061] 
26. Bosi G, Garani G, Scorrano M, Calzolari E. Temporal variability in birth prevalence of congenital 
heart defects as recorded by a general birth defects registry. J Pediatr. 2003; 142:690–698. 
[PubMed: 12838199] 
27. Martinez Oloron P, Romero Ibarra C, Alzina de Aguilar V. Incidence of congenital heart disease in 
Navarra (1989–1998). Rev Esp Cardiol. 2005; 58:1428–1434. [PubMed: 16371202] 
28. Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am Heart J. 2004; 
147:425–439. [PubMed: 14999190] 
29. Prsa M, Saroli T, Correa JA, Asgharian M, Mackie AS, Dancea AB. Birth prevalence of congenital 
heart disease. Epidemiology. 2009; 20:466–468. [PubMed: 19363360] 
30. Wu MH, Chen HC, Lu CW, Wang JK, Huang SC, Huang SK. Prevalence of congenital heart 
disease at live birth in Taiwan. J Pediatr. 2010; 156:782–785. [PubMed: 20138303] 
31. Jaeggi ET, Sholler GF, Jones OD, Cooper SG. Comparative analysis of pattern, management and 
outcome of pre- versus postnatally diagnosed major congenital heart disease: a population-based 
study. Ultrasound Obstet Gynecol. 2001; 17:380–385. [PubMed: 11380960] 
32. Driggers RW, Spevak PJ, Crino JP, Lantz M, Blakemore KJ. Fetal anatomic and functional 
echocardiography: a 5-year review. J Ultrasound Med. 2003; 22:45–51. [PubMed: 12523610] 
33. Strauss A, Toth B, Schwab B, et al. Prenatal diagnosis of congenital heart disease and neonatal 
outcome: a six years experience. Eur J Med Res. 2001; 6:66–70. [PubMed: 11313192] 
Zhang et al. Page 9
J Ultrasound Med. Author manuscript; available in PMC 2015 June 17.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Zhang et al. Page 10
Table 1
Sociodemographic Characteristics of Participants and Nonparticipants in Study Areas Near Shanghai, China, 
2004–2005
Characteristic
Participant Nonparticipant
n % n %
Maternal age, y 3,982 24.3 ± 3.1a 13,516 24.6 ± 3.6a
Location
 Suzhou 817 20.5 6,001 44.4
 Changshu 894 22.5 3,432 25.4
 Jiaxing 1,139 28.6 2,040 15.1
 Haining 1,132 28.4 2,043 15.1
Occupation
 Farmer 1,943 48.8 4,873 36.1
 Other 1,242 31.2 4,849 35.9
 Unemployed 730 18.3 3,697 27.4
 Unknown 67 1.7 97 0.7
Education
 College 858 21.6 3,376 25.0
 Middle school 2,962 74.4 9,628 71.2
 Primary school 100 2.5 438 3.2
 None 2 0.1 31 0.2
 Unknown 60 1.5 43 0.3
Ethnicity
 Han 3,911 98.2 13,436 99.4
 Other 12 0.3 73 0.5
 Unknown 59 1.5 7 0.1
Gravidity
 1 1,834 46.1 6,606 48.9
 2 1,382 34.7 4,378 32.4
 3+ 688 17.3 2,307 17.1
 Unknown 78 2.0 225 1.7
a
Mean ± SD.
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Table 3
Congenital Heart Defects Among 4006 Fetuses and Neonates in Study Areas Near Shanghai, China, 2004–
2005
Phenotype n % Prevalence per 1000 Births (95% CI)
Major 12 16.0 3.0 (1.6–5.2)
 Hypoplastic left heart syndrome 3 4.0 0.8 (0.2–2.2)
 Tetralogy of Fallot 4 5.3 1.0 (0.3–2.5)
 Transposition of the great arteries 1 1.3 0.3 (0.01–1.3)
 Atrioventricular septal defect 1 1.3 0.3 (0.01–1.3)
 Pulmonary atresia 1 1.3 0.3 (0.01–1.3)
 Critical pulmonary valve stenosis 1 1.3 0.3 (0.01–1.3)
 Anomalous pulmonary venous return 1 1.3 0.3 (0.01–1.3)
Minor 63 84.0 15.7 (12.2–20.0)
 Ventricular septal defect 47 62.7 11.7 (8.7–15.4)
 Atrial septal defect 14 18.7 3.5 (2.0–5.8)
 Mild pulmonary valve stenosis 1 1.3 0.3 (0.01–1.3)
 Coarctation of the aorta 1 1.3 0.3 (0.01–1.3)
Total 75 100.0 18.7 (14.8–23.5)
CI indicates confidence interval.
J Ultrasound Med. Author manuscript; available in PMC 2015 June 17.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Zhang et al. Page 13
Table 4
Major Congenital Heart Defects: Diagnoses and Pregnancy Outcomes in Study Areas Near Shanghai, China, 
2004–2005
Case n Diagnostic Procedure Agea Outcome
Hypoplastic left heart syndrome 3 Fetal echocardiography 22, 24, 25 Termination
Tetralogy of Fallotb 2 Fetal echocardiography/autopsy 25, 28 Termination
Pink tetralogy of Fallotc 2 Neonatal echocardiography 1.9 d Living
Transposition of the great arteries 1 Fetal echocardiography 27 Neonatal death
Atrioventricular septal defect 1 Fetal echocardiography 27 Termination
Pulmonary atresia 1 Fetal echocardiography/autopsy 23 Termination
Critical pulmonary valve stenosis 1 Fetal echocardiography/autopsy 25 Termination
Anomalous pulmonary venous return 1 Neonatal echocardiography 36 d Living
aWeeks’ gestation unless otherwise specified as days postnatally.
bOnly 1 fetus had an autopsy.
cOne fetus had a diagnosis of a ventricular septal defect on fetal echocardiography.
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